玩股撇步(動畫小學堂)  

  • 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
  • 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
  • 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
  • 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
  • 如果EPS衰退,要觀察同業是不是有一樣的狀況
  • 要留意增資減資和公司債對股本及EPS的影響
成長能力-近20季
加權平均股數 QoQ YoYEPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY營收 QoQ YoY毛利率(%) QoQ YoY營業利益率 QoQ YoY稅後淨利率 QoQ YoY營業利益 QoQ YoY稅後淨利 QoQ YoY稅前淨利率(%) QoQ YoY稅後淨利率(%) QoQ YoY兩季平均(YOY)營收成長率(%)兩季平均(YOY)EPS成長率(%)兩季平均(YOY)本業EPS成長率(%)
24Q3 (20)2060.00.0-0.71-44.9-20.34-0.63-21.155.97-1.86-61.7427.912.093.9884.96-32.93-30.7363.34-60.50-12.6450.27-70.11-38.4234.91-1.27-17.597.97-1.47-44.12-20.49-68.99-36.2935.31-70.11-38.4234.9177.61-9.570.62
24Q2 (19)2060.00.49-0.4925.7640.24-0.5222.3939.53-1.15-74.2442.212.01151.25-7.8-25.1976.740.38-53.7168.2933.84-50.6570.0534.02-1.0820.5938.98-1.0225.038.92-50.6269.533.63-50.6570.0534.0247.4818.296.28
24Q1 (18)2060.00.49-0.6610.8143.59-0.67-9.8411.84-0.6680.1243.590.8-56.28-42.03-108.11-156.37-43.57-169.37-151.96-42.62-169.11-102.842.88-1.36-10.5717.07-1.3610.5343.57-165.99-104.147.44-169.11-102.842.882.84-7.31-0.44
23Q4 (17)2060.024.85-0.74-25.4232.73-0.618.9625.61-3.32-28.68-21.171.8361.95-6.63-42.1753.05-27.13-67.2244.7424.67-83.3722.610.54-1.2310.8729.71-1.52-24.5916.94-81.3123.7515.78-83.3722.610.546.891.3115.53
23Q3 (16)2060.4932.9-0.5928.0547.32-0.6722.0914.1-2.58-29.65-46.591.13-48.17-28.93-89.82-112.59-93.0-121.65-49.85-18.72-107.71-40.30.83-1.3822.0315.34-1.2226.9529.48-106.64-39.823.61-107.71-40.30.834.9028.984.46
23Q2 (15)2050.033.12-0.8229.91-7.89-0.86-13.16-45.76-1.99-70.09-210.942.1857.9743.42-42.2543.89-20.54-81.1831.64-0.07-76.7755.910.04-1.77-7.93-43.9-1.6730.71-43.97-76.2757.470.85-76.7755.910.0414.1911.78-2.92
23Q1 (14)20524.2433.99-1.17-6.36-1075.0-0.767.32-1185.71-1.1757.3-1075.01.38-29.59-38.94-75.30-127.01-316.26-118.76-33.09-1779.77-174.12-86.84-2244.33-1.646.29-1125.0-2.41-31.69-1438.89-179.33-85.74-2222.25-174.12-86.84-2244.33-3.16-2.291.10
22Q4 (13)1656.4511.49-1.101.79-189.47-0.82-5.13-215.38-2.74-55.68-349.181.9623.27-11.31-33.1728.73-467.33-89.2312.92-271.79-93.1914.2-268.19-1.75-7.36-230.19-1.83-5.78-226.79-96.5512.73-291.05-93.1914.2-268.1913.94-22.79-18.67
22Q3 (12)1550.651.31-1.12-47.37-115.38-0.78-32.2-95.0-1.76-175.0-665.221.594.613.25-46.54-32.78-222.08-102.47-26.32-92.22-108.61-41.42-111.67-1.63-32.52-98.78-1.73-49.14-118.99-110.63-43.82-115.78-108.61-41.42-111.67-14.07-390.35-487.53
22Q2 (11)1540.650.65-0.76-733.33-68.89-0.59-942.86-84.37-0.64-633.33-300.01.52-32.7442.06-35.05-200.66-43.65-81.12-1247.38-33.88-76.80-1045.81-18.63-1.23-868.75-89.23-1.16-744.44-68.12-76.92-1010.3-18.85-76.80-1045.81-18.63-15.24-300.88-407.97
22Q1 (10)1533.3814.180.12131.58-85.880.07126.92-87.270.12119.67-85.882.262.26-22.634.82285.6-38.717.07129.46-81.988.12132.08-79.250.16130.19-86.090.18132.14-84.218.45134.22-78.588.12132.08-79.2522.8879.2580.96
21Q4 (9)148-3.2715.62-0.3826.92-280.0-0.2635.0-550.0-0.61-165.22-354.172.2143.5124.169.03162.49-48.52-24.0054.98-515.38-25.3150.67-264.17-0.5335.37-657.14-0.5629.11-366.67-24.6951.84-288.82-25.3150.67-264.1743.725.685.00
21Q3 (8)1530.019.53-0.52-15.56-372.73-0.40-25.0-566.67-0.23-171.88-167.651.5443.934.05-14.4540.78-216.53-53.3112.02-468.94-51.3120.74-455.3-0.82-26.15-485.71-0.79-14.49-464.29-51.2720.78-369.08-51.3120.74-455.3-9.71-84.25-91.59
21Q2 (7)15314.1820.47-0.45-152.94-172.58-0.32-158.18-178.050.32-62.35-28.891.07-63.36-60.22-24.40-142.95-150.9-60.59-254.41-298.33-64.74-265.41-321.41-0.65-156.52-179.27-0.69-160.53-187.34-64.72-264.1-324.41-64.74-265.41-321.410.34398.53658.41
21Q1 (6)1344.694.690.85950.0600.00.551475.0523.080.85254.17600.02.9264.04317.1456.81223.89399.6539.241106.15205.7439.14663.17226.581.151742.86542.311.141050.0618.1839.44721.1224.7739.14663.17226.5842.16479.55754.16
20Q4 (5)1280.01.59-0.109.0970.59-0.0433.3377.780.24-29.41113.791.7820.2735.8817.5441.45-52.99-3.9058.3887.09-6.9524.7878.59-0.0750.082.5-0.1214.2972.09-6.3541.981.25-6.9524.7878.59--0.00
20Q3 (4)1280.790.0-0.11-117.740.0-0.06-114.630.00.34-24.440.01.48-44.980.012.40-74.130.0-9.37-130.670.0-9.24-131.60.0-0.14-117.070.0-0.14-117.720.0-10.93-137.90.0-9.24-131.60.0--0.00
20Q2 (3)127-0.780.00.62464.710.00.41415.380.00.45364.710.02.69284.290.047.94321.640.030.55182.320.029.24194.570.00.82415.380.00.79459.090.028.84191.240.029.24194.570.0--0.00
20Q1 (2)1281.590.0-0.1750.00.0-0.1327.780.0-0.1790.230.00.7-46.560.011.37-69.530.0-37.11-22.880.0-30.924.740.0-0.2635.00.0-0.2248.840.0-31.616.650.0-30.924.740.0--0.00
19Q4 (1)1260.00.0-0.340.00.0-0.180.00.0-1.740.00.01.310.00.037.310.00.0-30.200.00.0-32.460.00.0-0.40.00.0-0.430.00.0-33.860.00.0-32.460.00.0--0.00
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比自結稅前EPS自結稅前累計EPS備註(年增率變動50%需說明原因)
2024/100.35-41.17-44.825.25-1.571.64N/A本公司以提供CDMO技術服務為主,收入係以滿足履約義務時認列,本月完成履約義務較去年同期減少。
2024/90.6-13.2635.754.94.32.090.35-
2024/80.69-13.6535.114.31.042.370.31-
2024/70.8-8.64346.123.61-3.612.270.32本公司以提供CDMO技術服務為主,收入係以滿足履約義務時認列,本月完成履約義務較去年同期增加。
2024/60.8847.03152.452.81-21.222.010.5本公司以提供CDMO技術服務為主,收入係以滿足履約義務時認列,本月完成履約義務較去年同期增加。
2024/50.611.65-43.141.93-39.951.540.65-
2024/40.5329.16-32.01.34-38.411.180.85-
2024/30.4175.05-5.120.8-42.050.81.38-
2024/20.2454.72-67.740.39-59.011.140.97本公司以提供CDMO技術服務為主,收入以滿足履約義務時認列,本月完成履約義務較少,致本月與本年度累計數較去年同期下滑。
2024/10.15-79.78-29.520.15-29.521.340.83-
2023/120.7573.44-26.126.53-10.871.830.61-
2023/110.44-31.92-19.855.77-8.41.520.74-
2023/100.6444.7462.255.34-7.321.590.7本公司以提供CDMO技術服務為主,收入係以滿足履約義務時認列,本月完成履約義務較去年同期增加
2023/90.44-13.67-42.134.7-12.431.131.19-
2023/80.51185.09-28.764.26-7.51.041.3-
2023/70.18-48.361.193.74-3.571.570.86本公司以提供CDMO技術服務為主,收入係以滿足履約義務時認列,本月完成履約義務較去年同期增加
2023/60.35-66.8860.243.56-5.492.180.76本公司以提供CDMO技術服務為主,收入係以滿足履約義務時認列,本月完成履約義務較去年同期增加。
2023/51.0533.5236.83.22-9.492.270.73-
2023/40.7980.2347.272.17-22.211.950.85-
2023/30.44-40.47-71.071.38-38.641.381.71係主因去年3月認列LusiNEX APA 114,260,000元的其他營業收入,故本月較去年同期減少
2023/20.73238.0234.680.9526.491.971.2-
2023/10.22-78.814.920.224.921.781.32-
2022/121.0288.154.767.32-5.421.961.26-
2022/110.5437.8362.366.3-6.891.71.45本公司以提供CDMO技術服務為主,收入係以滿足履約義務時認列,本月完成履約義務較去年同期增加
2022/100.39-48.37-56.195.76-10.491.881.32本公司以提供CDMO技術服務為主,收入係以滿足履約義務時認列,本月完成履約義務較去年同期減少
2022/90.766.27-7.865.36-3.061.591.42-
2022/80.72545.0948.274.6-2.221.052.16-
2022/70.11-48.61-51.943.88-8.011.092.07本公司以提供CDMO技術服務為主,收入係以滿足履約義務時認列,本月完成履約義務較去年同期減少
2022/60.22-71.72-2.163.77-5.461.521.46-
2022/50.7743.7548.753.55-5.652.810.79-
2022/40.53-64.5961.152.79-14.272.580.86係主因本公司以提供CDMO技術為主,收入係以滿足履約義務時認列,故本月營收較去年同期增加61.16%
2022/31.51177.1287.542.26-22.812.260.9主係本月認列LusiNEX114,260仟元之里程碑款,故本月營收較去年同期增加87.55%。
2022/20.54163.35112.480.75-64.621.721.18本月累計減少,係去年1月認列LusiNEX 155,705仟元收入。本月較去年同期增加,本月完成履約義務增加。
2022/10.21-78.84-88.920.21-88.921.521.35係主因去年1月認列LusiNEX APA155,705,000元的其他營業收入,故本月較去年同期減少88.93%
2021/120.98191.61100.127.7416.372.210.78本公司提供CDMO技術服務為主,收入係完成履約義務時認列,本月完成履約義務增加,故收入增加
2021/110.33-62.8117.336.779.752.060.84-
2021/100.98.56-10.926.439.382.210.78-
2021/90.8371.0319.795.5313.591.541.19-
2021/80.48109.06-8.584.7112.570.941.95-
2021/70.234.61-11.544.2215.640.971.89-
2021/60.22-57.01-86.93.9917.741.071.47去年同期營收較今年為高,主係109年6月認列出售LusiNEX相關資產之轉讓收入(Milestone 1 USD5,000,000)所致。
2021/50.5255.738.933.77122.061.650.95年營收增加係因CDMO業務持續成長及認列出售LusiNex相關資產之轉讓收入所致
2021/40.33-58.8-37.033.25165.761.391.13年營收增加係因認列出售LusiNEX相關資產之轉讓收入所致
2021/30.8213.97136.32.92318.282.920.46年營收增加係因CDMO業務持續成長及認列出售LusiNex相關資產之轉讓收入所致
2021/20.26-86.27-15.352.12490.592.610.52年營收增加因CDMO業務持續成長及認列出售LusiNEX相關資產之轉讓收入所致
2021/11.86282.413184.381.863184.382.640.51營收增加係因CDMO業務持續成長及認列出售LusiNEX相關資產之轉讓收入所致
2020/120.4970.9612.876.6570.231.780.48營收增加係因CDMO業務持續成長及認列出售LusiNEX相關資產之轉讓收入所致。
2020/110.29-71.76-59.836.1777.351.990.43年營收增加因CDMO業務持續成長及逐步認列出售LusiNEX之轉讓收入所致
2020/101.0146.0482.065.88112.532.230.38營收增加係因CDMO業務持續成長及認列出售LusiNEX相關資產之轉讓收入所致
2020/90.6930.51124.974.8787.811.480.54營收增加係因CDMO業務持續成長及認列出售LusiNEX相關資產之轉讓收入所致
2020/80.53102.3126.084.1882.822.480.32年營收增加係因CDMO業務持續成長及認列出售LusiNEX相關資產之轉讓收入所致。
2020/70.26-84.519.613.6577.882.430.33年營收增加係因CDMO業務持續成長及認列出售LusiNEX相關資產之轉讓收入所致。
2020/61.69257.7417.893.3986.882.690.26年營收增加係因CDMO業務持續成長及逐步認列出售LusiNEX相關資產之轉讓收入所致。
2020/50.47-9.99-28.291.714.151.340.52-
2020/40.5354.62221.891.2247.991.170.6本公司營收主要以接受客戶委託藥品開發的技術服務收入為主。此認列係以服務內容完成的進度認列收入,故變化較大。
2020/30.3412.46-4.950.75.240.70.83-
2020/20.3432.42322.340.3617.140.790.73本公司營收主要以接受客戶委託藥品開發的技術服務收入為主。此認列係以服務內容完成的進度認列收入,故變化較大。
2020/10.06-86.85-75.830.06-75.831.20.48本公司營收主要以接受客戶委託藥品開發的技術服務收入為主。此認列係以服務內容完成的進度認列收入,故變化較大。
2019/120.43-39.15-36.133.9184.860.0N/A本公司營收主要以接受客戶委託藥品開發的技術服務收入為主。此認列係以服務內容完成的進度認列收入,故變化較大。
2019/110.71309.08379.653.48141.730.0N/A本公司營收主要以接受客戶委託藥品開發的技術服務收入為主。此認列係以服務內容完成的進度認列收入,故變化較大。
成長能力-近10年
加權平均股數 YoYEPS YoY本業EPS YoY營收 YoY毛利率(%) YoY營業利益率 YoY稅後淨利率 YoY營業利益 YoY稅前淨利 YoY稅後淨利 YoY
2023 (10)20624.85-3.320-2.9206.53-10.79-57.490-92.260-104.630-6.020-6.840-6.830
2022 (9)16511.49-2.740-2.1207.32-5.43-15.520-60.770-61.950-4.450-4.630-4.540
2021 (8)14815.62-0.610-0.4307.7416.3917.77-36.63-11.020-11.610-0.850-0.880-0.90
2020 (7)1281.590.2400.1806.6570.0828.04-17.295.3204.6500.3500.2800.310
2019 (6)12614.55-1.740-1.0603.9185.3133.90408.25-58.910-55.820-2.30-2.30-2.180
2018 (5)1100.0-2.500-1.5102.11-33.866.67-84.8-152.550-129.800-3.230-2.860-2.740
2017 (4)1100.0-1.710-0.5003.1958.7143.88118.74-38.120-59.120-1.210-2.060-1.880
2016 (3)1100.0-1.450-1.0602.0148.8920.06-27.58-108.870-79.000-2.180-1.580-1.580
2015 (2)110-0.9-1.010-0.6901.3519.4727.70-29.84-104.610-82.230-1.410-1.10-1.110
2014 (1)11118.09-0.790-0.6501.1376.5639.480-117.470-77.050-1.330-0.860-0.870

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。